263 related articles for article (PubMed ID: 9683035)
21. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.
Riendeau D; Percival MD; Brideau C; Charleson S; Dubé D; Ethier D; Falgueyret JP; Friesen RW; Gordon R; Greig G; Guay J; Mancini J; Ouellet M; Wong E; Xu L; Boyce S; Visco D; Girard Y; Prasit P; Zamboni R; Rodger IW; Gresser M; Ford-Hutchinson AW; Young RN; Chan CC
J Pharmacol Exp Ther; 2001 Feb; 296(2):558-66. PubMed ID: 11160644
[TBL] [Abstract][Full Text] [Related]
22. The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa.
Tavares IA
Aliment Pharmacol Ther; 2000 Jun; 14(6):795-9. PubMed ID: 10848664
[TBL] [Abstract][Full Text] [Related]
23. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers.
Stichtenoth DO; Wagner B; Frölich JC
J Investig Med; 1998 Aug; 46(6):290-6. PubMed ID: 9737091
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.
Engelhardt G; Homma D; Schlegel K; Utzmann R; Schnitzler C
Inflamm Res; 1995 Oct; 44(10):423-33. PubMed ID: 8564518
[TBL] [Abstract][Full Text] [Related]
26. [Meloxicam (Mobic): a review of its pharmacological and clinical profile].
Ogino K; Saito K; Osugi T; Satoh H
Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):391-7. PubMed ID: 12528470
[TBL] [Abstract][Full Text] [Related]
27. Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings.
Engelhardt G; Bögel R; Schnitzer C; Utzmann R
Biochem Pharmacol; 1996 Jan; 51(1):21-8. PubMed ID: 8534264
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
29. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
Giuliano F; Warner TD
Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
[TBL] [Abstract][Full Text] [Related]
30. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
34. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.
Esser R; Berry C; Du Z; Dawson J; Fox A; Fujimoto RA; Haston W; Kimble EF; Koehler J; Peppard J; Quadros E; Quintavalla J; Toscano K; Urban L; van Duzer J; Zhang X; Zhou S; Marshall PJ
Br J Pharmacol; 2005 Feb; 144(4):538-50. PubMed ID: 15655513
[TBL] [Abstract][Full Text] [Related]
35. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.
Lazer ES; Miao CK; Cywin CL; Sorcek R; Wong HC; Meng Z; Potocki I; Hoermann M; Snow RJ; Tschantz MA; Kelly TA; McNeil DW; Coutts SJ; Churchill L; Graham AG; David E; Grob PM; Engel W; Meier H; Trummlitz G
J Med Chem; 1997 Mar; 40(6):980-9. PubMed ID: 9083488
[TBL] [Abstract][Full Text] [Related]
36. Changes in prostaglandin E2 (PGE2) levels in paw exudate, stomach and kidney of arthritic rats: effects of flosulide.
Turull A; Queralt J
Prostaglandins Other Lipid Mediat; 2001 Aug; 66(1):27-37. PubMed ID: 11519792
[TBL] [Abstract][Full Text] [Related]
37. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
[TBL] [Abstract][Full Text] [Related]
38. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
[TBL] [Abstract][Full Text] [Related]
39. Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats.
Giraudel JM; Toutain PL; Lees P
Am J Vet Res; 2005 Apr; 66(4):700-9. PubMed ID: 15900953
[TBL] [Abstract][Full Text] [Related]
40. Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles.
Fenner H
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):28-33. PubMed ID: 9219317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
